APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drugs and Devices

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Contraceptive Drugs and Devices Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchContraceptive Drugs and Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drugs and Devices Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Contraceptive Drugs and Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drugs and Devices Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drugs and Devices Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Drugs and Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Contraceptive Drugs and Devices include Teva Pharmaceutical Industries, Merck, Pfizer, Bayer Healthcare, Warmer Chilcott, Pantarhei Bioscience, Mayer Laboratories, Church & Dwight and BioSante Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Contraceptive Drugs and Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Contraceptive Drugs and Devices market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Contraceptive Drugs and Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Contraceptive Drugs and Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Contraceptive Drugs and Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Contraceptive Drugs and Devices Market by Company

Teva Pharmaceutical Industries

Merck

Pfizer

Bayer Healthcare

Warmer Chilcott

Pantarhei Bioscience

Mayer Laboratories

Church & Dwight

BioSante Pharmaceuticals

Agile Therapeutics

Contraceptive Drugs and Devices Segment by Type

Injectable Contraceptive Drugs

Vaginal

Male/Female Contraceptive Devices

Oral

Contraceptive Drugs and Devices Segment by Application

Hospitals

Pharmacies

Others

Contraceptive Drugs and Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drugs and Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drugs and Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drugs and Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Contraceptive Drugs and Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectable Contraceptive Drugs Table 2. Major Company of Vaginal Table 3. Major Company of Male/Female Contraceptive Devices Table 4. Major Company of Oral Table 5. Global Contraceptive Drugs and Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 7. Global Contraceptive Drugs and Devices Sales Market Share in Volume by Type (2021-2026) Table 8. Global Contraceptive Drugs and Devices Sales by Type (2021-2026) & (US$ Million) Table 9. Global Contraceptive Drugs and Devices Sales Market Share in Value by Type (2021-2026) Table 10. Global Contraceptive Drugs and Devices Price by Type (2021-2026) & (US$/unit) Table 11. Global Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 12. Global Contraceptive Drugs and Devices Sales Market Share in Volume by Type (2027-2032) Table 13. Global Contraceptive Drugs and Devices Sales by Type (2027-2032) & (US$ Million) Table 14. Global Contraceptive Drugs and Devices Sales Market Share in Value by Type (2027-2032) Table 15. Global Contraceptive Drugs and Devices Price by Type (2027-2032) & (US$/unit) Table 16. North America Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 17. North America Contraceptive Drugs and Devices Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 19. Europe Contraceptive Drugs and Devices Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Contraceptive Drugs and Devices Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 23. Latin America Contraceptive Drugs and Devices Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2021-2026) & (US$ Million) Table 26. Contraceptive Drugs and Devices Industry Trends Table 27. Contraceptive Drugs and Devices Industry Drivers Table 28. Contraceptive Drugs and Devices Industry Opportunities and Challenges Table 29. Contraceptive Drugs and Devices Industry Restraints Table 30. Global Contraceptive Drugs and Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Contraceptive Drugs and Devices Revenue Market Share by Company (2021-2026) Table 32. Global Contraceptive Drugs and Devices Sales by Company (2021-2026) & (k units) Table 33. Global Contraceptive Drugs and Devices Sales Share by Company (2021-2026) Table 34. Global Contraceptive Drugs and Devices Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Contraceptive Drugs and Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Contraceptive Drugs and Devices Major Company Production Sites and Headquarters Table 37. Global Contraceptive Drugs and Devices Company, Product Type & Application Table 38. Global Contraceptive Drugs and Devices Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Contraceptive Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Contraceptive Drugs and Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Contraceptive Drugs and Devices Sales by Region (2021-2026) & (k units) Table 43. Global Contraceptive Drugs and Devices Sales Market Share in Volume by Region (2021-2026) Table 44. Global Contraceptive Drugs and Devices Sales by Region (2021-2026) & (US$ Million) Table 45. Global Contraceptive Drugs and Devices Sales Market Share in Value by Region (2021-2026) Table 46. Global Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Contraceptive Drugs and Devices Sales by Region (2027-2032) & (k units) Table 48. Global Contraceptive Drugs and Devices Sales Market Share in Volume by Region (2027-2032) Table 49. Global Contraceptive Drugs and Devices Sales by Region (2027-2032) & (US$ Million) Table 50. Global Contraceptive Drugs and Devices Sales Market Share in Value by Region (2027-2032) Table 51. Global Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Contraceptive Drugs and Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 54. Global Contraceptive Drugs and Devices Sales Market Share in Volume by Application (2021-2026) Table 55. Global Contraceptive Drugs and Devices Sales by Application (2021-2026) & (US$ Million) Table 56. Global Contraceptive Drugs and Devices Sales Market Share in Value by Application (2021-2026) Table 57. Global Contraceptive Drugs and Devices Price by Application (2021-2026) & (US$/unit) Table 58. Global Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 59. Global Contraceptive Drugs and Devices Sales Market Share in Volume by Application (2027-2032) Table 60. Global Contraceptive Drugs and Devices Sales by Application (2027-2032) & (US$ Million) Table 61. Global Contraceptive Drugs and Devices Sales Market Share in Value by Application (2027-2032) Table 62. Global Contraceptive Drugs and Devices Price by Application (2027-2032) & (US$/unit) Table 63. North America Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 64. North America Contraceptive Drugs and Devices Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 66. Europe Contraceptive Drugs and Devices Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Contraceptive Drugs and Devices Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 70. Latin America Contraceptive Drugs and Devices Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries Company Information Table 74. Teva Pharmaceutical Industries Business Overview Table 75. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio Table 77. Teva Pharmaceutical Industries Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merck Contraceptive Drugs and Devices Product Portfolio Table 82. Merck Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Pfizer Contraceptive Drugs and Devices Product Portfolio Table 87. Pfizer Recent Development Table 88. Bayer Healthcare Company Information Table 89. Bayer Healthcare Business Overview Table 90. Bayer Healthcare Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio Table 92. Bayer Healthcare Recent Development Table 93. Warmer Chilcott Company Information Table 94. Warmer Chilcott Business Overview Table 95. Warmer Chilcott Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio Table 97. Warmer Chilcott Recent Development Table 98. Pantarhei Bioscience Company Information Table 99. Pantarhei Bioscience Business Overview Table 100. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio Table 102. Pantarhei Bioscience Recent Development Table 103. Mayer Laboratories Company Information Table 104. Mayer Laboratories Business Overview Table 105. Mayer Laboratories Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio Table 107. Mayer Laboratories Recent Development Table 108. Church & Dwight Company Information Table 109. Church & Dwight Business Overview Table 110. Church & Dwight Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Church & Dwight Contraceptive Drugs and Devices Product Portfolio Table 112. Church & Dwight Recent Development Table 113. BioSante Pharmaceuticals Company Information Table 114. BioSante Pharmaceuticals Business Overview Table 115. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio Table 117. BioSante Pharmaceuticals Recent Development Table 118. Agile Therapeutics Company Information Table 119. Agile Therapeutics Business Overview Table 120. Agile Therapeutics Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio Table 122. Agile Therapeutics Recent Development Table 123. North America Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. North America Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 125. North America Contraceptive Drugs and Devices Sales Market Share by Country (2021-2026) Table 126. North America Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032) & (k units) Table 127. North America Contraceptive Drugs and Devices Sales Market Share Forecast by Country (2027-2032) Table 128. North America Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Contraceptive Drugs and Devices Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Contraceptive Drugs and Devices Market Share by Country (2021-2026) Table 131. North America Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Contraceptive Drugs and Devices Market Share Forecast by Country (2027-2032) Table 133. Europe Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Europe Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 135. Europe Contraceptive Drugs and Devices Sales Market Share by Country (2021-2026) Table 136. Europe Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032) & (k units) Table 137. Europe Contraceptive Drugs and Devices Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Contraceptive Drugs and Devices Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Contraceptive Drugs and Devices Market Share by Country (2021-2026) Table 141. Europe Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Contraceptive Drugs and Devices Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 145. Asia-Pacific Contraceptive Drugs and Devices Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032) & (k units) Table 147. Asia-Pacific Contraceptive Drugs and Devices Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Contraceptive Drugs and Devices Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Contraceptive Drugs and Devices Market Share by Country (2021-2026) Table 151. Asia-Pacific Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Contraceptive Drugs and Devices Market Share Forecast by Country (2027-2032) Table 153. Latin America Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Latin America Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 155. Latin America Contraceptive Drugs and Devices Sales Market Share by Country (2021-2026) Table 156. Latin America Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032) & (k units) Table 157. Latin America Contraceptive Drugs and Devices Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Contraceptive Drugs and Devices Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Contraceptive Drugs and Devices Market Share by Country (2021-2026) Table 161. Latin America Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Contraceptive Drugs and Devices Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 165. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032) & (k units) Table 167. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Contraceptive Drugs and Devices Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Contraceptive Drugs and Devices Market Share by Country (2021-2026) Table 171. Middle East and Africa Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Contraceptive Drugs and Devices Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Contraceptive Drugs and Devices Distributors List Table 176. Contraceptive Drugs and Devices Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Contraceptive Drugs and Devices Image Figure 2. Global Contraceptive Drugs and Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Drugs and Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Drugs and Devices Sales (2021-2032) & (k units) Figure 5. Injectable Contraceptive Drugs Image Figure 6. Global Injectable Contraceptive Drugs Sales YoY Growth (2021-2032) & (k units) Figure 7. Vaginal Image Figure 8. Global Vaginal Sales YoY Growth (2021-2032) & (k units) Figure 9. Male/Female Contraceptive Devices Image Figure 10. Global Male/Female Contraceptive Devices Sales YoY Growth (2021-2032) & (k units) Figure 11. Oral Image Figure 12. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Contraceptive Drugs and Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Contraceptive Drugs and Devices Market Share by Type 2025 VS 2032 Figure 15. North America Contraceptive Drugs and Devices Sales Market Share in Volume by Type in 2025 Figure 16. North America Contraceptive Drugs and Devices Sales Market Share in Value by Type in 2025 Figure 17. Europe Contraceptive Drugs and Devices Sales Market Share in Volume by Type in 2025 Figure 18. Europe Contraceptive Drugs and Devices Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Contraceptive Drugs and Devices Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Contraceptive Drugs and Devices Sales Market Share in Value by Type in 2025 Figure 21. Latin America Contraceptive Drugs and Devices Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Contraceptive Drugs and Devices Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Contraceptive Drugs and Devices Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 29. Pharmacies Image Figure 30. Global Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Contraceptive Drugs and Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Contraceptive Drugs and Devices Market Share by Application 2025 VS 2032 Figure 35. North America Contraceptive Drugs and Devices Sales Market Share in Volume by Application in 2025 Figure 36. North America Contraceptive Drugs and Devices Sales Market Share in Value by Application in 2025 Figure 37. Europe Contraceptive Drugs and Devices Sales Market Share in Volume by Application in 2025 Figure 38. Europe Contraceptive Drugs and Devices Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Contraceptive Drugs and Devices Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Contraceptive Drugs and Devices Sales Market Share in Value by Application in 2025 Figure 41. Latin America Contraceptive Drugs and Devices Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Contraceptive Drugs and Devices Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share in Value by Application in 2025 Figure 45. North America Contraceptive Drugs and Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Contraceptive Drugs and Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Contraceptive Drugs and Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Contraceptive Drugs and Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Contraceptive Drugs and Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Contraceptive Drugs and Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Contraceptive Drugs and Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Contraceptive Drugs and Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Contraceptive Drugs and Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Contraceptive Drugs and Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Contraceptive Drugs and Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Contraceptive Drugs and Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Contraceptive Drugs and Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Contraceptive Drugs and Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Contraceptive Drugs and Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Contraceptive Drugs and Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Contraceptive Drugs and Devices Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Contraceptive Drugs and Devices Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Contraceptive Drugs
  • Vaginal
  • Male/Female Contraceptive Devices
  • Oral
Applications
  • Hospitals
  • Pharmacies
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Merck
  • Pfizer
  • Bayer Healthcare
  • Warmer Chilcott
  • Pantarhei Bioscience
  • Mayer Laboratories
  • Church & Dwight
  • BioSante Pharmaceuticals
  • Agile Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contraceptive Drugs and Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Contraceptive Drugs and Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Contraceptive Drugs and Devices Market by Type
  6. 1.3.1 Injectable Contraceptive Drugs
  7. 1.3.2 Vaginal
  8. 1.3.3 Male/Female Contraceptive Devices
  9. 1.3.4 Oral
  10. 1.4 Global Contraceptive Drugs and Devices Market Size by Type
  11. 1.4.1 Global Contraceptive Drugs and Devices Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Contraceptive Drugs and Devices Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Contraceptive Drugs and Devices Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Contraceptive Drugs and Devices Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Contraceptive Drugs and Devices Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Contraceptive Drugs and Devices Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Contraceptive Drugs and Devices Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Contraceptive Drugs and Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Contraceptive Drugs and Devices Industry Trends
  2. 2.2 Contraceptive Drugs and Devices Industry Drivers
  3. 2.3 Contraceptive Drugs and Devices Industry Opportunities and Challenges
  4. 2.4 Contraceptive Drugs and Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Contraceptive Drugs and Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Contraceptive Drugs and Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Contraceptive Drugs and Devices Price (2021-2026)
  4. 3.4 Global Contraceptive Drugs and Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contraceptive Drugs and Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Contraceptive Drugs and Devices Company, Product Type & Application
  7. 3.7 Global Contraceptive Drugs and Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contraceptive Drugs and Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contraceptive Drugs and Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contraceptive Drugs and Devices Tier 1, Tier 2, and Tier 3
4 Contraceptive Drugs and Devices Regional Status and Outlook
  1. 4.1 Global Contraceptive Drugs and Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Contraceptive Drugs and Devices Historic Market Size by Region
  3. 4.2.1 Global Contraceptive Drugs and Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Contraceptive Drugs and Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Contraceptive Drugs and Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Contraceptive Drugs and Devices Forecasted Market Size by Region
  7. 4.3.1 Global Contraceptive Drugs and Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Contraceptive Drugs and Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Contraceptive Drugs and Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Contraceptive Drugs and Devices by Application
  1. 5.1 Contraceptive Drugs and Devices Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Contraceptive Drugs and Devices Market Size by Application
  6. 5.2.1 Global Contraceptive Drugs and Devices Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Contraceptive Drugs and Devices Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Contraceptive Drugs and Devices Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Contraceptive Drugs and Devices Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Contraceptive Drugs and Devices Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Contraceptive Drugs and Devices Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Contraceptive Drugs and Devices Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Contraceptive Drugs and Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Contraceptive Drugs and Devices Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Contraceptive Drugs and Devices Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Bayer Healthcare
  20. 6.4.1 Bayer Healthcare Company Information
  21. 6.4.2 Bayer Healthcare Business Overview
  22. 6.4.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio
  24. 6.4.5 Bayer Healthcare Recent Developments
  25. 6.5 Warmer Chilcott
  26. 6.5.1 Warmer Chilcott Company Information
  27. 6.5.2 Warmer Chilcott Business Overview
  28. 6.5.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio
  30. 6.5.5 Warmer Chilcott Recent Developments
  31. 6.6 Pantarhei Bioscience
  32. 6.6.1 Pantarhei Bioscience Company Information
  33. 6.6.2 Pantarhei Bioscience Business Overview
  34. 6.6.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio
  36. 6.6.5 Pantarhei Bioscience Recent Developments
  37. 6.7 Mayer Laboratories
  38. 6.7.1 Mayer Laboratories Company Information
  39. 6.7.2 Mayer Laboratories Business Overview
  40. 6.7.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio
  42. 6.7.5 Mayer Laboratories Recent Developments
  43. 6.8 Church & Dwight
  44. 6.8.1 Church & Dwight Company Information
  45. 6.8.2 Church & Dwight Business Overview
  46. 6.8.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio
  48. 6.8.5 Church & Dwight Recent Developments
  49. 6.9 BioSante Pharmaceuticals
  50. 6.9.1 BioSante Pharmaceuticals Company Information
  51. 6.9.2 BioSante Pharmaceuticals Business Overview
  52. 6.9.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio
  54. 6.9.5 BioSante Pharmaceuticals Recent Developments
  55. 6.10 Agile Therapeutics
  56. 6.10.1 Agile Therapeutics Company Information
  57. 6.10.2 Agile Therapeutics Business Overview
  58. 6.10.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio
  60. 6.10.5 Agile Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Contraceptive Drugs and Devices Sales by Country
  2. 7.1.1 North America Contraceptive Drugs and Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Contraceptive Drugs and Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Contraceptive Drugs and Devices Market Size by Country
  6. 7.2.1 North America Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Contraceptive Drugs and Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Contraceptive Drugs and Devices Sales by Country
  2. 8.1.1 Europe Contraceptive Drugs and Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Contraceptive Drugs and Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Contraceptive Drugs and Devices Market Size by Country
  6. 8.2.1 Europe Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Contraceptive Drugs and Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Contraceptive Drugs and Devices Sales by Country
  2. 9.1.1 Asia-Pacific Contraceptive Drugs and Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Contraceptive Drugs and Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Contraceptive Drugs and Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Contraceptive Drugs and Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Contraceptive Drugs and Devices Sales by Country
  2. 10.1.1 South America Contraceptive Drugs and Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Contraceptive Drugs and Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Contraceptive Drugs and Devices Market Size by Country
  6. 10.2.1 South America Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Contraceptive Drugs and Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Country
  2. 11.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Contraceptive Drugs and Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Contraceptive Drugs and Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Contraceptive Drugs and Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Contraceptive Drugs and Devices Value Chain Analysis
  2. 12.1.1 Contraceptive Drugs and Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Contraceptive Drugs and Devices Production Mode & Process
  7. 12.2 Contraceptive Drugs and Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Contraceptive Drugs and Devices Distributors
  10. 12.2.3 Contraceptive Drugs and Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst